Loading...

Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling

Molecular targeting therapies often cause characteristic adverse effects, such as skin rash during anti-epidermal growth factor receptor (EGFR) therapies, making treatment continuation difficult. In contrast, skin symptoms induced by EGFR inhibition are strongly correlated with the overall survival...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Pharmaceuticals (Basel)
Main Authors: Nishiya, Naoyuki, Murai, Moeka, Hosoda, Ayumi, Yonezawa, Honami, Omori, Norikazu
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6958386/
https://ncbi.nlm.nih.gov/pubmed/31703435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph12040165
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!